PMID: 9181235Jun 1, 1997Paper

Cisplatin-based chemotherapy changes the incidence of bilateral testicular cancer

Annals of Surgical Oncology
J P van BastenH Schraffordt Koops

Abstract

The introduction of cisplatin-based chemotherapy has remarkably increased the survival of testicular cancer patients. With this success, the concern for a contralateral testicular tumor has increased. The aim of this study was to investigate whether the risk for contralateral testicular tumor development was influenced by cisplatin-based chemotherapy. The incidence of a contralateral testicular tumor among 365 consecutive patients with a nonseminoma testicular tumor, diagnosed in the period 1980 and 1995, was established and related to previous therapy. Eleven of 365 men (3%) developed a contralateral testicular tumor. After a total of 2403 person-years at risk, 4 of 225 chemotherapy-treated patients (1.8%) developed a contralateral testicular tumor, and 7 of 140 patients (5%) treated with orchidectomy alone developed a contralateral tumor. In comparison to this surveillance subgroup, patients previously treated with chemotherapy have a relative risk of 0.30 to develop a second testicular tumor. In Dutch men with a nonseminoma testicular tumor, the incidence of a contralateral testicular tumor is 3%, which is 60-fold the expected incidence rate of testicular cancer. A three times lower incidence rate of a contralateral testicul...Continue Reading

References

Oct 2, 1991·Journal of the National Cancer Institute·A OsterlindL H Rasmussen
Jun 1, 1990·International Journal of Radiation Oncology, Biology, Physics·A HellbardtJ P Paunier
Aug 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G StoterH M Pinedo
Feb 27, 1988·Lancet·H von der MaaseN E Skakkebaek
Jul 1, 1987·The Journal of Urology·K ScheiberU E Studer
Apr 1, 1980·British Journal of Urology·M SokalW F Hendry
Dec 1, 1983·International Journal of Andrology·P H WillemseH Doorenbos
May 1, 1983·The Journal of Urology·D W BachJ H Hartlapp
Aug 1, 1983·The Journal of Urology·A G CockburnW F Whitmore
Feb 1, 1982·Urology·H J HoekstraH Schraffordt Koops
Apr 1, 1982·Urology·S M WareP Morales
May 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M E GelsH Schraffordt Koops
Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C Bokemeyer, H J Schmoll
Feb 1, 1995·British Journal of Cancer·P W Nicholson, S J Harland
Jan 1, 1995·The Journal of Urology·A HeidenreichD M Wilbert
Jan 1, 1995·The Journal of Urology·L Weissbach
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C BokemeyerH Poliwoda
Mar 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F E van LeeuwenR Somers
Oct 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G A van der SandenF E van Leeuwen
Sep 1, 1995·Cancer Treatment Reviews·J P van BastenH J Hoekstra
Feb 1, 1996·The Journal of Urology·Y AraiO Yoshida
Mar 1, 1996·The Journal of Urology·I LeibovitchJ P Donohue

❮ Previous
Next ❯

Citations

Jul 11, 2002·The Lancet Oncology·Joost BartElisabeth G E de Vries
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D J SonneveldH J Hoekstra
Sep 1, 2007·International Journal of Urology : Official Journal of the Japanese Urological Association·Eri TomitaKazunari Tanabe
Mar 21, 2012·BJU International·Stenio de Cassio ZequiGustavo C Guimaraes
Jun 1, 2011·International Journal of Cancer. Journal International Du Cancer·Kristine E AndreassenSophie D Fosså
Sep 3, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J BartW T A van der Graaf
Sep 24, 1999·The Urologic Clinics of North America·T M Ulbright
Aug 1, 1997·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J P van BastenH J Hoekstra
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sigmund BrabrandGustav Lehne
Jan 15, 2014·Urologia·Giuseppe PalermoGaetano Gulino
Oct 13, 2012·British Journal of Cancer·M SchaapveldF E van Leeuwen
Oct 30, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joost M BlokMichael Schaapveld

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.